Quotient Therapeutics Ltd is a privately held, early-stage company developing a novel genomics platform and therapeutics for diseases with a large unmet need. The company was founded by Flagship Pioneering, an innovative enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Generate Biomedicines, Sana Biotechnology (SANA), Tessera Therapeutics, Evelo Biosciences (EVLO), Indigo Agriculture, Seres Therapeutics (MCRB), and Syros Pharmaceuticals (SYRS). We are an equal opportunity employer. We are seeking a motivated and creative Senior Research Associate to join our team focused on performing in vitro studies to characterize novel somatic variants in the context of Cardiometabolic disease. This role requires a strong background in life sciences to execute experiments that investigate somatic variant function to validate potential drug targets. The position involves a combination of hands-on lab work, data analysis, and scientific communication to ensure a target's potential benefit for a disease. The successful candidate will be a self-starter, able to thrive in a fast-paced, action-oriented team environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
251-500 employees